Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SEC (Securities and Exchange Commission) warns Lumenis over likely legal action

This article was originally published in Clinica

Executive Summary

The US Securities and Exchange Commission (SEC) has sent Yokneam, Israel-based Lumenis a Wells Notice, indicating that it may be preparing civil proceedings against the laser therapy firm. The move comes as part of an investigation by the SEC's Boston district office into Lumenis's accounts. Lumenis will now have time to discuss the issues with the SEC before the latter decides what action to take.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts